Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian Drug Makers Move To Novel Drug Delivery Systems

This article was originally published in PharmAsia News

Executive Summary

India is expected to ride the drug industry trend toward new ways to deliver new drugs to patients, a growing segment of the pharmaceutical industry. Many Indian drug makers are working on novel drug discovery systems, already comprising nearly six percent of the Indian market. Revenues from NDDS products are expected to generate 29 percent annual growth in India, compared with 17 percent by the industry at large. Much of the new focus by drug makers results from a shrinking number of innovative drugs coming on the market at the same time blockbuster drugs lose their patent protections. (Click here for more

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts